| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $471.5M | $345.3M | $280.7M |
| YoY Revenue Growth % | +36.6% | +23.0% | — |
| Gross Profit | $190.0M | $132.1M | — |
| Gross Margin % | 40.3% | 38.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $72.9M | $63.6M | $48.5M |
| Operating Margin % | 15.5% | 18.4% | 17.3% |
| Net Income (GAAP) | $17.4M | $12.7M | $4.4M |
| EBITDA (Normalized) | $89.2M | $75.8M | $58.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$22.1M | $26.6M | $20.3M |
| Capital Expenditures (CapEx) | $20.3M | $15.3M | $12.6M |
| Free Cash Flow (FCF) | -$42.5M | $11.4M | $7.7M |
| FCF Margin % | -9.0% | 3.3% | 2.7% |
| Return on Invested Capital (ROIC %) | 8.6% | 11.3% | 2.1% |
| Cash & Short-Term Equivalents | $34.0M | $11.5M | — |
| Total Debt (Short + Long Term) | $324.6M | $260.1M | $711.1M |
| Total Stockholders' Equity | $382.7M | $196.0M | $1.46B |